{"filing":{"accession_number":"0001193125-26-347839","cik":"0001832332","ticker":"AVAH","company_name":"Aveanna Healthcare Holdings, Inc.","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"avah-20260319.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1832332/000119312526347839/avah-20260319.htm"},"events":[{"id":27448,"run_id":25023,"accession_number":"0001193125-26-347839","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Aveanna Healthcare disclosed Q2 2026 financial results showing revenue of $670.5 million (13.7% YoY increase), net income of $40.3 million, and Adjusted EBITDA of $95.4 million, along with raised full-year 2026 guidance for revenue (greater than $2.68 billion) and Adjusted EBITDA (greater than $365 million).","company_name":"Aveanna Healthcare Holdings, Inc.","ticker":"AVAH","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":28999,"accession_number":"0001193125-26-347839","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Aveanna Healthcare's financial results for Q2 2026 (three and six-month periods ended July 4, 2026). The press release, furnished as Exhibit 99.1, reports revenue of $670.5 million (13.7% YoY increase), net income of $40.3 million, and Adjusted EBITDA of $95.4 million, along with revised full-year 2026 guidance raising revenue expectations to greater than $2.68 billion and Adjusted EBITDA to greater than $365 million. This is a material disclosure affecting investor assessment of the company's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:02:07.067465+00:00","company_name":"","ticker":null,"filing_date":""},{"id":29000,"accession_number":"0001193125-26-347839","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"The filing discloses Aveanna Healthcare's second quarter 2026 financial results, including revenue of $670.5 million (13.7% YoY increase), net income of $40.3 million, and Adjusted EBITDA of $95.4 million. The company also raised full-year 2026 guidance for both revenue (to greater than $2.68 billion) and Adjusted EBITDA (to greater than $365 million). This is a standard earnings release with detailed quarterly and six-month financial performance metrics, material to investors assessing the company's operational performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:02:07.067465+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28999,"accession_number":"0001193125-26-347839","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Aveanna Healthcare's financial results for Q2 2026 (three and six-month periods ended July 4, 2026). The press release, furnished as Exhibit 99.1, reports revenue of $670.5 million (13.7% YoY increase), net income of $40.3 million, and Adjusted EBITDA of $95.4 million, along with revised full-year 2026 guidance raising revenue expectations to greater than $2.68 billion and Adjusted EBITDA to greater than $365 million. This is a material disclosure affecting investor assessment of the company's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:02:07.067465+00:00","company_name":"Aveanna Healthcare Holdings, Inc.","ticker":"AVAH","filing_date":"2026-08-13"},{"id":29000,"accession_number":"0001193125-26-347839","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"The filing discloses Aveanna Healthcare's second quarter 2026 financial results, including revenue of $670.5 million (13.7% YoY increase), net income of $40.3 million, and Adjusted EBITDA of $95.4 million. The company also raised full-year 2026 guidance for both revenue (to greater than $2.68 billion) and Adjusted EBITDA (to greater than $365 million). This is a standard earnings release with detailed quarterly and six-month financial performance metrics, material to investors assessing the company's operational performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:02:07.067465+00:00","company_name":"Aveanna Healthcare Holdings, Inc.","ticker":"AVAH","filing_date":"2026-08-13"}]}